'GLP-1 Face': Facial Volume Loss on GLP-1 Medications

You have seen pictures of celebrities or influencers on GLP-1 medications, and you have noticed their faces look different. Sharper cheekbones. Hollowed-out temples. A gaunt appearance that did not match the rest of their weight loss story.

This is “GLP-1 face.” And it is a legitimate concern for people considering GLP-1 therapy.

The direct answer: Yes, some people on GLP-1 medications experience noticeable facial volume loss. It is real, it is primarily a result of rapid fat loss rather than a direct medication effect, and there are specific strategies that may reduce its severity.

This article explains what is actually happening in your face during weight loss on GLP-1, who is affected most, the role of age and collagen in how your skin responds, and the evidence-based approaches to minimize the changes while still achieving your weight loss goals.

What “GLP-1 face” actually is

The phenomenon popularly called “GLP-1 face” is a colloquial term for noticeable facial volume loss that can occur during significant weight loss on GLP-1 medications. The changes typically include a more defined or angular jawline, more prominent cheekbones, hollowing of the temples, and sometimes a slightly sunken appearance around the eyes and under the chin.

This is not a condition unique to GLP-1 medications. The same facial changes can occur during any significant weight loss, including from aggressive calorie restriction, bariatric surgery, or serious illness. The term caught on because GLP-1 medications are widely used and make meaningful weight loss more common than it was before.

The changes are mainly cosmetic. On their own, they do not usually point to a medical problem, though losing weight much more quickly than expected or having trouble eating enough is worth raising with your provider. They are a visible sign that your body is burning fat at a faster rate than your skin and supporting tissues can adjust to.

The biology: Why facial fat changes during weight loss

To understand why “GLP-1 face” happens, you need to understand how facial fat works.

Your face contains several pads of subcutaneous fat (fat lying beneath the skin) that give your face its shape, volume, and youthful fullness. The main ones are the buccal fat pads (inside your cheeks), the temporal fat pads (above your cheekbones), and the orbital fat (around the eyes). These are not cosmetic luxuries. They provide structure, support the skin, and influence how light reflects off your face.

During weight loss, your body mobilizes fat from all over your body as energy. The rate at which facial fat disappears depends on several factors, but the mechanism is simple: as your total body fat decreases, the fat pads in your face shrink proportionally.

Many people notice changes in their face early, sometimes before they see much change around the abdomen. Facial fat pads are relatively small and sit close to the surface, so even a modest loss of volume can be visible. How quickly each area changes varies from person to person.

When weight loss is slow (0.5 to 1 pound per week), your body has time to adjust. Skin maintains some elasticity, and the loss of volume happens gradually enough that your face simply looks “thinner,” which most people perceive as positive. When weight loss is faster (2 to 3 pounds per week or more), the facial fat disappears faster than the skin can adapt, creating a hollow or gaunt appearance.

The role of collagen and skin laxity

Facial volume loss would be minor if it were only about fat. The real age accelerator is what happens to your skin when fat is lost rapidly, particularly in people over 40.

Your skin is supported by two main proteins: collagen and elastin. Collagen provides structure and firmness. Elastin provides bounce-back and flexibility. Collagen production and skin elasticity decline with age, and estrogen decline during perimenopause and menopause speeds that up.^[3]

When fat is lost slowly, the skin has time to gradually contract and re-drape over the smaller facial structure. The remaining collagen and elastin can maintain some firmness. When fat is lost rapidly, the skin loses its support faster than it can remodel. This leaves you with loose or lax skin in areas where fat was lost, combined with the appearance of sunkenness. Studies of skin after large weight loss (in people who had bariatric surgery) have found lower collagen content and collagen fibers that are thinner and less organized.^[1][2]

This is particularly relevant for women 35 to 50 experiencing perimenopause. During this transition, estrogen decline itself reduces collagen production and skin thickness. Add faster-paced weight loss on top of that, and the facial skin may look noticeably different. It is not vanity to recognize this. It is a real biological consequence of the intersection between hormonal change and significant weight loss.

Who experiences the most noticeable changes

Facial volume loss is not universal on GLP-1 medications. Some people lose significant weight and experience minimal facial changes, while others notice changes after relatively modest weight loss. Several factors influence how much facial change you will experience:

Rate of weight loss: The faster you lose weight, the more noticeable facial changes will be. People losing 2 to 3 pounds per week typically see more dramatic facial changes than those losing 0.5 to 1 pound per week.

Age and skin elasticity: People over 40, particularly those over 50, notice more pronounced facial changes because their skin has less collagen and elastin to support rapid volume loss. Younger skin can bounce back more effectively.

Starting BMI: People with higher starting BMI often have larger facial fat pads, so the absolute volume loss is greater and more visible. A 50-pound weight loss looks more dramatic on someone who started at 220 pounds than on someone who started at 160 pounds.

Genetics: Some people have facial anatomy predisposed to showing volume loss more (naturally prominent cheekbones, less subcutaneous fat to begin with). Genetics play a significant role in how dramatic the changes appear.

Sex and hormonal status: Women, particularly perimenopausal women, often experience more noticeable facial changes than men, partly because of lower baseline collagen density during hormonal transition, and partly because facial fullness is culturally coded as feminine, so the loss is more noticeable to the observer.

None of these factors mean you should not pursue weight loss. They simply mean you are not imagining the changes if you notice them, and you can take specific action to mitigate them.

Prevention and mitigation strategies

There is no way to completely prevent facial volume loss if you are losing fat. The loss of facial fat is a natural consequence of fat loss. However, there are evidence-based strategies that can reduce the speed and severity of the changes.

Slower weight loss pace is the most effective lever

This is the most direct intervention available to you.

If you slow your weight loss from 2 to 3 pounds per week to 0.5 to 1 pound per week, your skin has far more time to adjust. The collagen and elastin can gradually remodel, and the visual appearance of the facial changes is much less dramatic.

Your prescriber decides the dose escalation schedule, and some prescribers use a slower titration (gradual dose increase) to manage side effects. If facial changes are a priority for you, tell your provider at the start, and ask how they handle pace and dose changes.

The tradeoff is clear: slower weight loss means it takes longer to reach your goal. For some people, that trade is worth it. For others, minimal facial changes are less important than faster progress. Both approaches are valid.

Adequate protein intake supports skin structure

Protein is the building block for collagen and skin elastin. When your body is in a caloric deficit and protein intake is insufficient, it may break down body proteins, including those in muscle and connective tissue, to preserve critical functions.

During active weight loss, aim for 1.2 to 1.6 grams of protein per kilogram of body weight per day. For a 170-pound woman, that is approximately 92 to 123 grams daily. For a 220-pound woman, it is approximately 120 to 160 grams daily.

Adequate protein helps preserve lean mass during weight loss, but direct evidence that extra protein protects facial skin is limited. It will not prevent facial volume loss, though it supports the tissues your skin depends on.

A registered dietitian, or a program that includes nutrition support, can help you plan how to hit these targets even with appetite suppression.

Resistance training preserves lean mass and skin structure

When you lose weight through a combination of calorie restriction and resistance training, more of the weight loss comes from fat and less from muscle and connective tissue. Some early research suggests resistance training may also support skin thickness, though the evidence is limited.

This is not about aesthetic improvement of the face directly. It is about preserving the lean mass (muscle and connective tissue) that supports your overall appearance and metabolic health. The secondary benefit is that your face may retain more structure if you are preserving muscle mass elsewhere in your body.

Aim for 2 to 3 sessions of resistance training per week during weight loss.

Hydration and basic skin care

This is less direct than the strategies above, but worth noting: adequate hydration supports skin elasticity, and basic skincare (moisturizer, sunscreen) can slow visible aging on the face.

There is emerging (but not yet conclusive) evidence that collagen peptide supplements may support skin collagen density, though the clinical effect is modest. Discuss any supplements with your provider.

Dermatologist consultation for more significant concerns

If you experience more severe facial volume loss and it is bothersome to you, a dermatologist can discuss options. These might include dermal fillers, radiofrequency treatments, or other aesthetic approaches. These are optional, carry their own risks and costs, and would be decisions you make with a specialist, separate from your GLP-1 prescription.

The point: if the changes are significant, you have options available, but you do not need them. Many people accept the facial changes as a reasonable tradeoff for the metabolic health benefits of weight loss.

Realistic expectations

Many people see mild to moderate facial volume loss as a reasonable tradeoff for meaningful weight loss and improvements in metabolic health markers like blood sugar, blood pressure, and cholesterol. For context, in the SURMOUNT-1 trial, adults taking tirzepatide lost an average of 15 to 21 percent of body weight at 72 weeks, depending on dose, compared with about 3 percent on placebo^[4]. Results vary, and trial averages are not a prediction for any individual.

The facial changes are temporary in the sense that they stabilize once weight loss stabilizes. Some volume may return over time as you reach a maintenance phase and your body’s composition stabilizes. The changes are not progressive indefinitely.

If you are deeply concerned about facial changes, here is the conversation to have with your provider: discuss your rate of weight loss, your protein intake strategy, your resistance training plan, and your personal priorities. Your provider can help you set a plan that aligns with what matters most to you.

For some people, that means accepting more noticeable facial changes in exchange for faster progress. For others, it means choosing a slower pace to minimize changes. A good prescriber should not push maximum weight loss in minimum time. If you are still choosing a program, ask how its prescribers handle pace and dose changes when your priorities include limiting facial changes.

The broader context

Facial volume loss is one of several body-composition changes that can occur during significant weight loss on GLP-1 medications. If you are concerned about other changes (skin texture, body shape, body satisfaction), the same principle applies: these are consequences of fat loss and metabolic change, not direct medication side effects, and you have agency in calibrating the pace of change.

The decision to start GLP-1 therapy is a personal one. This article is meant to remove one barrier from that decision: uncertainty about what facial changes actually are and what you can do about them.

Next steps

If you are considering GLP-1 therapy and facial changes are a concern, talk to your provider about your priorities before you start. Discuss your preferred weight loss pace, your protein intake strategy, and whether resistance training is realistic for your situation. If you are already on GLP-1 and noticing facial changes, contact your provider to discuss whether adjusting your dosing schedule or other aspects of your program might help.

The goal is not to avoid all facial change (that is not realistic if you are losing fat). The goal is to make informed choices about the pace and visibility of those changes, aligned with what matters most to you.

Related reading

Learn more about body changes during GLP-1 weight loss and strategies to support your health and appearance.

Citations

[1] Rocha RI, Junior WC, Modolin MLA, et al. Skin Changes Due to Massive Weight Loss: Histological Changes and the Causes of the Limited Results of Contouring Surgeries. Obes Surg. 2021;31(4):1505-1513. https://pubmed.ncbi.nlm.nih.gov/33145720/ (Collagen remodeling in abdominal skin after bariatric-surgery weight loss.)

[2] Orpheu SC, Coltro PS, Scopel GP, et al. Collagen and elastic content of abdominal skin after surgical weight loss. Obes Surg. 2010;20(4):480-486. https://pubmed.ncbi.nlm.nih.gov/19937152/ (Lower collagen content in lax abdominal skin after massive weight loss.)

[3] Viscomi B, Muniz M, Sattler S. Managing Menopausal Skin Changes: A Narrative Review of Skin Quality Changes, Their Aesthetic Impact, and the Actual Role of Hormone Replacement Therapy in Improvement. J Cosmet Dermatol. 2025;24 Suppl 4:e70393. https://pubmed.ncbi.nlm.nih.gov/40847905/ (Estrogen decline is linked to lower collagen production and reduced skin elasticity.)

[4] Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/ (Average weight loss of 15.0% to 20.9% across tirzepatide doses vs 3.1% with placebo at 72 weeks.)